期刊
DIABETOLOGIA
卷 55, 期 10, 页码 2741-2746出版社
SPRINGER
DOI: 10.1007/s00125-012-2649-3
关键词
De novo ceramide synthesis; Ex vivo SPT activity; HepG2 liver cells; Lipid infusion; Liver; Myriocin
资金
- National Health and Medical Research Council (NHMRC) of Australia
- Monash University Fellowship
- National Institutes of Health
- NHMRC Biomedical Australian Training Fellowship
- NHMRC Career Development Award
- NHMRC Senior Research Fellowship
- National Institutes of Health (NIH) [R01 DK077966, P30-DK-089503]
- NIH [R24 HD050837, P30 AR058878]
Plasma ceramide concentrations correlate with insulin sensitivity, inflammation and atherosclerotic risk. We hypothesised that plasma ceramide concentrations are increased in the presence of elevated fatty acid levels and are regulated by increased liver serine C-palmitoyltransferase (SPT) activity. Lean humans and rats underwent an acute lipid infusion and plasma ceramide levels were determined. One group of lipid-infused rats was administered myriocin to inhibit SPT activity. Liver SPT activity was determined in lipid-infused rats, and obese, insulin resistant mice. The time and palmitate dose-dependent synthesis of intracellular and secreted ceramide was determined in HepG2 liver cells. Plasma ceramide levels were increased during lipid infusion in humans and rats, and in obese, insulin-resistant mice. The increase in plasma ceramide was not associated with changes in liver SPT activity, and inhibiting SPT activity by similar to 50% did not alter plasma ceramide levels in lipid-infused rats. In HepG2 liver cells, palmitate incorporation into extracellular ceramide was both dose- and time-dependent, suggesting the liver cells rapidly secreted the newly synthesised ceramide. Elevated systemic fatty acid availability increased plasma ceramide but this was not associated with changes in hepatic SPT activity, suggesting that liver ceramide synthesis is driven by substrate availability rather than increased SPT activity. This report also provides evidence that the liver is sensitive to the intracellular ceramide concentration, and an increase in liver ceramide secretion may help protect the liver from the deleterious effects of intracellular ceramide accumulation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据